Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 19 results found. Search for [ viral vector vaccine ]

Results 1 to 19 of 19
BusinessToday.In
October 13, 2020
\"We're expecting that early next year we should have vaccine in the country from maybe more than one source,\" says union health minister Harsh Vardhan


Reuters
October 1, 2020
AstraZeneca's large, late-stage U.S. trial has remained on hold since Sept. 6, after a study participant in Britain fell ill with what was believed to be a rare spinal inflammatory disorder called transverse myelitis


BusinessToday.In
September 18, 2020
Russian COVID-19 vaccine: Volunteers would receive a second shot of the Russian COVID-19 vaccine within 21 days of the first shot. The adenovirus-based viral vector vaccine is yet to complete a large-scale clinical trial but has been approved by the Russian government


PB Jayakumar
September 4, 2020
Given that temperature requirements are likely to be the main challenge, regions with a particularly warm climate and those with limited cold-chain logistics infrastructure will pose the biggest challenge


BusinessToday.In
August 29, 2020
COVID-19 vaccine update: The expert group of the committee, headed by Dr. VK Paul, is also in contact with domestic as well as multinational vaccine makers to understand how soon a COVID-19 vaccine will be ready


PB Jayakumar
August 5, 2020
The vaccine, using the platform of plasmid DNA, was found to be safe and well tolerated in the Phase I, which began on 15 July, said Zydus Cadila


E Kumar Sharma
July 3, 2020
Zydus Cadila is second in India after Bharat Biotech to receive DCGI nod for human trials of vaccine candidate


BusinessToday.In
June 23, 2020
COVID-19 vaccine latest news update: Herbal medicine company Patanjali Ayurved, on Tuesday, launched 'Coronil' and 'Swasari', its Ayurvedic medicines claiming to treat COVID-19 patients within 14 days


BusinessToday.In
June 22, 2020
COVID-19 vaccine latest news: Biotechnology and pharmaceutical firms comprising Moderna Inc, and AstraZeneca, have been accelerating the pace of their production, promising millions of supplies of their experimental vaccines before this year-end


BusinessToday.In
June 21, 2020
COVID-19 vaccine latest news update: The phase-2 trial will evaluate the shot's dose and continue to determine whether the potential vaccine can safely trigger immune responses in healthy people


BusinessToday.In
New Delhi, June 17, 2020
Coronavirus vaccine, drug update: After low doses of dexamethasone were found to have reduced deaths among patients, hopes have risen about a possible cure for coronavirus infection


PB Jayakumar
May 6, 2020
Regulatory agencies have fast-tracked the vaccine development, which normally takes 7-10 years to reach the market


Reuters
April 30, 2020
Only a handful of the vaccines in development have advanced to human trials, an indicator of safety and efficacy - and the stage where most vaccines fail


PB Jayakumar
April 29, 2020
Biocon is developing a customised non-replicating measles virus based vaccine for coronavirus, a latest antigen therapy that can be commercialised quickly, along with two new generation repurposed drugs and an antibody diagnostic kit


PB Jayakumar and E Kumar Sharma
New Delhi, April 28, 2020
Seven Indian firms are among those hunting for a vaccine to tame Covid-19. Here is how the projects are progressing


PB Jayakumar
April 5, 2020
India's Zydus Cadila, Serum Institute and Bharat Biotech are among the global firms working on COVID-19 vaccine


PB Jayakumar
March 29, 2020
Typically, only one in ten experimental vaccines make it all the way through to regulatory approval. Therefore, different approaches mean the chances of success are higher


PTI
May 16, 2019



By E. Kumar Sharma
Delhi, May 9, 2016
It's ancient, pesky, and persistent. Its hum can spell impending doom. But the ubiquitous mosquito also drills a hole in your pocket triggering demand for hospitals, clinics, diagnostic kits, even some FMCG products. Not to forget the money going into R&D for medicines.


PAGES 1 OF 1